In the future, these findings may prove significant for the assessment of breast cancer prognosis and treatment planning. The study involved 270 breast cancer patients at Kuopio University Hospital, aged between 32 and 86 years. Breast tissue density was analysed on the basis of mammographic images obtained at the time of diagnosis…
HSCT (also known as blood and marrow transplant) is most often used to treat diseases of the blood and several types of cancer such as multiple myeloma or leukemia. For many people with these diseases the only possibility of a cure is to have a HSCT. The procedure provides healthy cells from either the patient (autologous transplantation) or from a healthy donor (allogeneic transplantation) to replace those lost to disease or chemotherapy…
In the future, the newly developed technique will enable increasingly accurate image acquisition especially during PET scans performed to detect cancers of the chest and upper abdomen, and inflammatory diseases of the heart. PET scanning, or positron emission tomography, is a modern nuclear medicine imaging method, which allows for the detection of cancer and heart conditions. Thanks to enhanced image quality, PET images provide new and increasingly accurate data, potentially improving diagnosis reliability and treatment response monitoring. High-quality image data makes the treatment more efficient both medically and financially. …
source : http://www.sciencedaily.com/releases/2014/07/140721123743.htm
source : http://www.sciencedaily.com/releases/2014/05/140528145817.htm
source : http://www.sciencedaily.com/releases/2014/05/140529092607.htm
source : http://www.sciencedaily.com/releases/2014/01/140127093148.htm
But the society has also warned that a worrying lack of information about the situation in Eastern Europe must be urgently addressed. Published in the Annals of Oncology this week, the survey provides the first detailed information on the current number of medical oncologists in 12 European Union countries, mostly in Western Europe, and their predicted availability by 2020. Around the world countries are struggling to ensure their medical oncology systems can deal with the increase in cancer cases, says ESMO Press Officer Solange Peters, a lung cancer expert from the university of Lausanne, Switzerland. Until now, nobody could say what the situation was in Europe. …
But early transplantation does appear to be beneficial among a small group of patients who are at the very highest risk, the study found. Lead author is Patrick Stiff, MD, director of Loyola University Medical Center’s Cardinal Bernardin Cancer Center. The study was developed by the SWOG cancer research cooperative group and funded by the National Cancer Institute. Stiff is chair of the SWOG Bone Marrow and Stem Cell Transplantation Committee. …
An enzyme that metabolizes the glucose needed for tumor growth is found in high concentrations in cancer cells, but in very few normal adult tissues. Deleting the gene for the enzyme stopped the growth of cancer in laboratory mice, with no associated adverse effects, reports Nissim Hay, UIC professor of biochemistry and molecular genetics, and his colleagues in the August 12 issue of Cancer Cell…